Idexx Laboratories Stock Short Ratio
IDXX Stock | USD 494.26 0.46 0.09% |
IDEXX Laboratories fundamentals help investors to digest information that contributes to IDEXX Laboratories' financial success or failures. It also enables traders to predict the movement of IDEXX Stock. The fundamental analysis module provides a way to measure IDEXX Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IDEXX Laboratories stock.
IDEXX | Short Ratio |
IDEXX Laboratories Company Short Ratio Analysis
IDEXX Laboratories' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current IDEXX Laboratories Short Ratio | 4.54 X |
Most of IDEXX Laboratories' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IDEXX Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
IDEXX Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for IDEXX Laboratories is extremely important. It helps to project a fair market value of IDEXX Stock properly, considering its historical fundamentals such as Short Ratio. Since IDEXX Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of IDEXX Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of IDEXX Laboratories' interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition |
IDEXX Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, IDEXX Laboratories has a Short Ratio of 4.54 times. This is 16.41% higher than that of the Health Care Equipment & Supplies sector and 21.99% lower than that of the Health Care industry. The short ratio for all United States stocks is 13.5% lower than that of the firm.
IDEXX Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IDEXX Laboratories' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics of similar companies.IDEXX Laboratories is currently under evaluation in short ratio category among related companies.
IDEXX Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, IDEXX Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to IDEXX Laboratories' managers, analysts, and investors.Environment Score | Governance Score | Social Score |
IDEXX Laboratories Institutional Holders
Institutional Holdings refers to the ownership stake in IDEXX Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of IDEXX Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing IDEXX Laboratories' value.Shares | Brown Advisory Holdings Inc | 2023-12-31 | 1.2 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.1 M | Capital World Investors | 2023-12-31 | 1 M | Norges Bank | 2023-12-31 | 922.8 K | Northern Trust Corp | 2023-12-31 | 862.6 K | Jpmorgan Chase & Co | 2023-12-31 | 860.5 K | Fundsmith Investment Services Ltd. | 2023-12-31 | 818.6 K | Legal & General Group Plc | 2023-12-31 | 787.2 K | Principal Financial Group Inc | 2023-12-31 | 781.4 K | Blackrock Inc | 2023-12-31 | 9.1 M | Vanguard Group Inc | 2023-12-31 | 8.4 M |
IDEXX Fundamentals
Return On Equity | 0.81 | ||||
Return On Asset | 0.23 | ||||
Profit Margin | 0.23 % | ||||
Operating Margin | 0.27 % | ||||
Current Valuation | 41.64 B | ||||
Shares Outstanding | 83.05 M | ||||
Shares Owned By Insiders | 0.92 % | ||||
Shares Owned By Institutions | 92.24 % | ||||
Number Of Shares Shorted | 1.76 M | ||||
Price To Earning | 61.31 X | ||||
Price To Book | 27.85 X | ||||
Price To Sales | 11.29 X | ||||
Revenue | 3.66 B | ||||
Gross Profit | 2 B | ||||
EBITDA | 1.1 B | ||||
Net Income | 845.04 M | ||||
Cash And Equivalents | 114.36 M | ||||
Cash Per Share | 1.37 X | ||||
Total Debt | 947.88 M | ||||
Debt To Equity | 3.27 % | ||||
Current Ratio | 0.89 X | ||||
Book Value Per Share | 17.88 X | ||||
Cash Flow From Operations | 906.51 M | ||||
Short Ratio | 4.54 X | ||||
Earnings Per Share | 10.07 X | ||||
Price To Earnings To Growth | 4.75 X | ||||
Target Price | 604.62 | ||||
Number Of Employees | 11 K | ||||
Beta | 1.26 | ||||
Market Capitalization | 41.01 B | ||||
Total Asset | 3.26 B | ||||
Retained Earnings | 4.44 B | ||||
Working Capital | 543.71 M | ||||
Current Asset | 821.63 M | ||||
Current Liabilities | 856.76 M | ||||
Net Asset | 3.26 B |
About IDEXX Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IDEXX Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
IDEXX Laboratories Investors Sentiment
The influence of IDEXX Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in IDEXX. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to IDEXX Laboratories' public news can be used to forecast risks associated with an investment in IDEXX. The trend in average sentiment can be used to explain how an investor holding IDEXX can time the market purely based on public headlines and social activities around IDEXX Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
IDEXX Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for IDEXX Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average IDEXX Laboratories' news discussions. The higher the estimated score, the more favorable is the investor's outlook on IDEXX Laboratories.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IDEXX Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IDEXX Laboratories' short interest history, or implied volatility extrapolated from IDEXX Laboratories options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out IDEXX Laboratories Piotroski F Score and IDEXX Laboratories Altman Z Score analysis. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
CEOs Directory Screen CEOs from public companies around the world | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.121 | Earnings Share 10.07 | Revenue Per Share 44.073 | Quarterly Revenue Growth 0.088 | Return On Assets 0.2283 |
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.